Barrington Research reissued their outperform rating on shares of Paysign (NASDAQ:PAYS – Free Report) in a research note published on Monday, Benzinga reports. The brokerage currently has a $7.00 target price on the stock.
Paysign Stock Performance
Shares of PAYS stock remained flat at $3.66 during midday trading on Monday. The company’s stock had a trading volume of 6,464 shares, compared to its average volume of 252,206. Paysign has a one year low of $1.94 and a one year high of $5.59. The stock has a 50-day simple moving average of $4.05 and a 200 day simple moving average of $4.36. The firm has a market capitalization of $194.49 million, a PE ratio of 26.14 and a beta of 0.95.
Insider Buying and Selling at Paysign
In other news, CEO Mark Newcomer sold 50,000 shares of Paysign stock in a transaction dated Monday, September 23rd. The shares were sold at an average price of $4.25, for a total value of $212,500.00. Following the sale, the chief executive officer now owns 9,486,886 shares of the company’s stock, valued at $40,319,265.50. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Paysign news, CEO Mark Newcomer sold 50,000 shares of the firm’s stock in a transaction on Monday, September 23rd. The stock was sold at an average price of $4.25, for a total value of $212,500.00. Following the completion of the sale, the chief executive officer now owns 9,486,886 shares of the company’s stock, valued at approximately $40,319,265.50. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Daniel Spence sold 100,000 shares of the business’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $3.60, for a total transaction of $360,000.00. Following the sale, the insider now directly owns 9,090,000 shares in the company, valued at approximately $32,724,000. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 211,000 shares of company stock valued at $800,260. 23.30% of the stock is owned by company insiders.
Institutional Investors Weigh In On Paysign
About Paysign
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Recommended Stories
- Five stocks we like better than Paysign
- What Are Dividend Champions? How to Invest in the Champions
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
- What is the Nikkei 225 index?
- NXP Semiconductors Nears Rock Bottom: A Buy Signal Is Expected
- What to Know About Investing in Penny Stocks
- NVIDIA, Sherwin-Williams Join the Dow: What Investors Should Know
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.